Event Profile: Where Legacy Meets Innovation

The 19th MegaGen International Symposium

This content is sponsored by MegaGen America.

The 19th MegaGen International Symposium, held in Toronto, Canada, marked a historic milestone in implant dentistry. Under the theme “Reviewing the Past 50 Years, Envisioning the Next 50 in Implant Dentistry,” the symposium gathered over 1,300 global clinicians and researchers. Toronto holds immense symbolic value for the field; it is where the 1982 Toronto Conference established the concept of osseointegration. Returning to this historic cradle, MegaGen—in a landmark alliance with Nobel Biocare—critically re-evaluated legacy paradigms to chart a patient-centric path for the next half-century.


A confluence of living legends and master clinicians
The symposium’s authority was underscored by an unprecedented lineup of 14 global dental icons, bridging the founding generation with modern innovators.

The Pioneers
Prof. Tomas Albrektsson, who established modern implant success criteria, challenged conventional views on marginal bone loss. He presented meta-analysis data demonstrating it to be an immune-mediated, aseptic response rather than peri-implantitis. Alongside him, Prof. Dennis Tarnow and Prof. David Garber shared invaluable insights on the 50-year evolution of aesthetic dentistry and immediate loading.

The Innovators
Dr. Paulo Maló, the creator of the All-on-4 treatment concept, reflected on 25 years of disruptive innovation across more than 250,000 cases. Prof. Tomas Linkevicius, founder of the ‘Zero Bone Loss’ concept, provided evidence-based protocols to turn old contraindications into routine indications.

The Future Visionaries
Leading minds like Prof. Alessandro Pozzi and Digital Dentistry Society president Prof. Francesco Mangano demonstrated the transformative power of AI, navigation, and seamless digital workflows.

Furthermore, the historic collaboration between MegaGen’s MINEC and Nobel Biocare’s Foundation for Oral Rehabilitation established a shared mission to deliver safer, more predictable treatments worldwide.


The New Toronto Declaration: 13 paradigms for future innovation
Moving beyond “clinical inertia,” MegaGen officially unveiled The New Toronto Declaration, a framework of 13 new standards driven by deeper biological understanding and long-term clinical data (Table 1).

Dr. Kwang-Bum Park, CEO of MegaGen, catalyzed this shift during his lecture on the “Fourth Revolution.” He emphasized that with an aging patient demographic, aggressive bone grafting is no longer the default answer. “The next era of implant dentistry will be measured by how gently and efficiently we restore a patient’s quality of life,” Park stated.

A living museum of seamless technology
The on-site experience extended far beyond the lecture hall. MegaGen’s exhibition space was transformed into a “dental museum,” featuring an Honorary Zone dedicated to the pioneers of the past 50 years. Alongside this heritage showcase, MegaGen presented its Seamless Digital Solution, demonstrating how integrated workflows—from initial diagnosis to final restoration—can eliminate stress for clinicians while saving time and reducing costs for patients.


Conclusion
The 19th MegaGen International Symposium successfully redefined foundational dogmas, equipping clinicians with immediate, evidence-based protocols and fusing dentistry with advanced sciences like AI and biomimetic robotics.

Building on this monumental success, the global dental community now looks forward to the 20th MegaGen International Symposium, scheduled for April 16–17, 2027, at the Shanghai World Expo Exhibition & Convention Center in Shanghai, China, to continue defining the future of dental innovation.